Jason B Fincham, DO | |
122 Pinnell St, Ripley, WV 25271-9101 | |
(304) 372-2731 | |
Not Available |
Full Name | Jason B Fincham |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 16 Years |
Location | 122 Pinnell St, Ripley, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902066889 | NPI | - | NPPES |
WV0247A | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 2443 (West Virginia) | Secondary |
207Q00000X | Family Medicine | 2443 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Minnie Hamilton Health System | Grantsville, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Minnie Hamilton Health Care Center Inc | 2961311667 | 19 |
News Archive
A 15 year study in 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men. The research was presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Dr Ghanshyam Shantha, a cardiovascular disease fellow at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that a profile of the company and its pipeline is featured in the November 21 issue of BioWorld Today in the NewCo section.
There are now two reasons for patients to flinch at the touch of a stethoscope: because it's cold, of course; and because it's covered with germs.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
› Verified 4 days ago
Entity Name | Minnie Hamilton Health Care Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124029400 PECOS PAC ID: 2961311667 Enrollment ID: O20031204000002 |
News Archive
A 15 year study in 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men. The research was presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Dr Ghanshyam Shantha, a cardiovascular disease fellow at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that a profile of the company and its pipeline is featured in the November 21 issue of BioWorld Today in the NewCo section.
There are now two reasons for patients to flinch at the touch of a stethoscope: because it's cold, of course; and because it's covered with germs.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
› Verified 4 days ago
Entity Name | Greenbrier Emergency Services, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568401461 PECOS PAC ID: 2668377359 Enrollment ID: O20031205000043 |
News Archive
A 15 year study in 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men. The research was presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Dr Ghanshyam Shantha, a cardiovascular disease fellow at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that a profile of the company and its pipeline is featured in the November 21 issue of BioWorld Today in the NewCo section.
There are now two reasons for patients to flinch at the touch of a stethoscope: because it's cold, of course; and because it's covered with germs.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
› Verified 4 days ago
Entity Name | Community Health Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649277476 PECOS PAC ID: 1759291313 Enrollment ID: O20031219000784 |
News Archive
A 15 year study in 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men. The research was presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Dr Ghanshyam Shantha, a cardiovascular disease fellow at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that a profile of the company and its pipeline is featured in the November 21 issue of BioWorld Today in the NewCo section.
There are now two reasons for patients to flinch at the touch of a stethoscope: because it's cold, of course; and because it's covered with germs.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Jason B Fincham, DO 186 Hospital Dr, Grantsville, WV 26147-7100 Ph: (304) 354-9244 | Jason B Fincham, DO 122 Pinnell St, Ripley, WV 25271-9101 Ph: (304) 372-2731 |
News Archive
A 15 year study in 1.1 million patients with atrial fibrillation has found that women are 23% more likely to be hospitalised for acute ischaemic stroke than men. The research was presented today at CARDIOSTIM - EHRA EUROPACE 2016 by Dr Ghanshyam Shantha, a cardiovascular disease fellow at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, US.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that a profile of the company and its pipeline is featured in the November 21 issue of BioWorld Today in the NewCo section.
There are now two reasons for patients to flinch at the touch of a stethoscope: because it's cold, of course; and because it's covered with germs.
Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.
› Verified 4 days ago
Brandon August Cestaric, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 512a South Church Street, Ripley, WV 25271 Phone: 304-372-1033 Fax: 304-373-0223 | |
Dr. Andria M. Allen, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 South Church Street, Suite 3, Ripley, WV 25271 Phone: 681-661-0123 | |
Craig Swann, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 122 Pinnell St, Ripley, WV 25271 Phone: 304-372-3506 | |
Timothy P Metzger, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 512a Church St S, Ripley, WV 25271 Phone: 304-372-1033 Fax: 304-373-0223 |